-
What does ExeVir Bio do?
- ExeVir Bio is a biotechnology company focused on developing innovative therapies against viral infections. The company specializes in the use of its proprietary technology to create monoclonal antibodies that target and neutralize viruses. ExeVir Bio aims to address urgent medical needs in infectious diseases through its advanced research and development efforts.
-
Company number
-
0750.495.334
-
Location
- Rijvisschestraat 120 Gent 9052
-
Founding date
- Founded in 10-07-2020
-
Juridical situation
- Normale toestand
-
Juridical form
- Besloten Vennootschap
-
Type of enterprise
- Rechtspersoon
Very high risk
High risk
Average
Low risk
Very low risk
| Financial ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity |
€
10.44M
-33.51%
|
€
15.70M
-9.93%
|
€
17.43M
|
| Profit |
€
-5.61M
-148.93%
|
€
-2.25M
92.15%
|
€
-28.74M
|
| EBITDA |
€
-229K
-102.22%
|
€
10.31M
733.5%
|
€
1.24M
|
| Gross margin |
€
2.27M
-80.93%
|
€
11.91M
371.64%
|
€
2.53M
|
| Debt |
€
2.20M
-28.6%
|
€
3.08M
-77.78%
|
€
13.85M
|
| Cash |
€
3.41M
-69.06%
|
€
11.02M
-45.38%
|
€
20.17M
|
| Employees |
8.00
-11.11%
|
9.00
-8.16%
|
9.80
|
Directors
All directors
Activities according to NACEBEL codes
Activities
VAT Activities
Social Security Activities
Publications 10
All publicationsSimilar companies
Show allFrequently asked questions
The VAT number of ExeVir Bio is BE0750.495.334.
In 2023, ExeVir Bio employed 8.00 full-time equivalents (FTE).
ExeVir Bio was founded in 10-07-2020.
The official address of ExeVir Bio is Rijvisschestraat 120 Gent 9052 .
The juridical form of ExeVir Bio is Besloten Vennootschap.
The legal situation of ExeVir Bio is Normale toestand.
The annual revenue of ExeVir Bio is €0.
ExeVir Bio is a biotechnology company focused on developing innovative therapies against viral infections. The company specializes in the use of its proprietary technology to create monoclonal antibodies that target and neutralize viruses. ExeVir Bio aims to address urgent medical needs in infectious diseases through its advanced research and development efforts.
Sources
Ready to start?
Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.
